The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?
Lobular carcinoma in situ was first described over 60 years ago. Despite the long history, it continues to pose significant difficulties in screening, diagnosis, management and treatment. This is partly due its multi-focal and bilateral presentation, an incomplete understanding of its biology and natural history and perpetuation of misconceptions gathered over the last decades. In this review, the working group on behalf of EUSOMA has attempted to summarise the current thinking and management of this interesting lesion.
Lakhani
Sunil R
SR
Molecular and Cellular Pathology, School of Medicine, The University of Queensland, Mayne Medical School, Brisbane, QLD 4006, Australia. s.lakhani@uq.edu.au
Audretsch
Werner
W
Cleton-Jensen
Anne-Marie
AM
Cutuli
Bruno
B
Ellis
Ian
I
Eusebi
Vincenzo
V
Greco
Marco
M
Houslton
Richard S
RS
Kuhl
Christiane K
CK
Kurtz
John
J
Palacios
Jose
J
Peterse
Hans
H
Rochard
France
F
Rutgers
E
E
D000328:Adult; D001943:Breast Neoplasms / Q000175:diagnosis / Q000628:therapy; D002278:Carcinoma in Situ / Q000175:diagnosis / Q000628:therapy; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis / Q000628:therapy; D018275:Carcinoma, Lobular / Q000175:diagnosis / Q000628:therapy; D005260:Female; D006801:Humans; D008875:Middle Aged